rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapyGiovanna Polcaro, Francesco Sabbatino|Journal for ImmunoTherapy of Cancer|2025Cited by 1